We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Creo Medical Group Plc | LSE:CREO | London | Ordinary Share | GB00BZ1BLL44 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.75 | 34.50 | 35.00 | 35.00 | 34.75 | 34.75 | 703,104 | 10:20:49 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 27.17M | -26.94M | -0.0746 | -4.66 | 125.53M |
Date | Subject | Author | Discuss |
---|---|---|---|
03/12/2018 12:41 | Creo Medical announces first use of Speedboat in mainland Europe: | xj25vm | |
03/12/2018 10:54 | Seriously...is nobody else quite encouraged by this?"The Company remains on track with the establishment of a training-centric commercialisation programme in the US and looks forward to updating shareholders on progress before the year end." | dplewis1 | |
22/10/2018 11:29 | Creo Medical @CreoMedical · 17 minutes ago Hello from UEG Week Vienna! Come and visit us Booth 14, Hall x3 to see the device that one clinician called “the holy grail of therapeutic endoscopy!” #uegweek | someuwin | |
19/10/2018 16:47 | Anyone go to the presentation? Any feedback? What is their IP they hold as this is key to others entering the market. | nimbo10 | |
19/10/2018 16:24 | Yeah it's a bit of a winner in terms of an investment case. I did some research a while ago into competition and I did find some (a Johnson & Johnson owned company called Ethicon has a microwave ablation machine) but CREO does seem to have a massive headstart in the GI tract area. If they can start showing the benefits of the products with lung cancer and other tumours then that would present a huge opportunity. | dplewis1 | |
19/10/2018 16:11 | The Investor's Presentation is almost too good to believe. Is there a catch? So far ~50 human procedures so absolutely ground zero for the products. 187 worldwide patents with 385 patents pending. Global market around $3Bn. They look like an experienced team. Plus scope (pardon the pun) to get into pancreatic and lung cancers. And they claim minimal competition. | drbob_ceng | |
19/10/2018 07:19 | Also the slides are available from Wednesday:http://inv | dplewis1 | |
18/10/2018 08:45 | Cenkos today "Creo Medical Group Plc Commercial progress Creo Medical has announced its first mainland Europe distribution agreements covering Spain, the Netherlands, Belgium and Luxemburg. These announcements follow similar agreements covering the UK, South Africa and Asia-Pacific and further demonstrate the progress which Creo is making on the commercial front. We maintain our Buy recommendation." | someuwin | |
17/10/2018 15:30 | It dropped from 8 quid to 1 quid I think I might give that a swerve.. | dplewis1 | |
17/10/2018 14:47 | You wanna look at Farn :) | toffeeman | |
17/10/2018 12:19 | So it's not amazing news :) | toffeeman | |
17/10/2018 11:25 | Yes pretty much priced in. Still an all round confidence builder though as they deliver on their strategy repeatedly | dplewis1 | |
17/10/2018 10:28 | I would have thought that the real news would have been if they were not securing distribution! Surely this is as expected? | toffeeman | |
17/10/2018 09:19 | Yup - no reason these products can't be rolled out worldwide. Better results. Quicker. More cost effective etc. | someuwin | |
17/10/2018 07:11 | RNS.. that's amazing news. Developed markets in Europe are huge for med tech products, this appears to be going global. | dplewis1 | |
02/10/2018 08:17 | Can buy £2k online. But not £3k. So stock supply is still tight. | someuwin | |
01/10/2018 16:33 | Crikey. Every time I check in on this one it's gone up again..what a fantastic share | dplewis1 | |
01/10/2018 12:32 | Can't get a buy quote for just £1k | someuwin | |
01/10/2018 08:08 | Up and running. | someuwin |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions